Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2012 by National Cancer Institute (NCI).
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01124695
First received: May 14, 2010
Last updated: December 6, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)